Back to List

Regenerative Medicinal Products Act - Article 1

Regenerative Medicinal Products Act｜第 1 條｜Food and Drug Administration｜Act｜In Force

衛生福利部｜v1.0

Effective Date: 2026-01-01｜Last Amended: 2024-06-19

Content

The Regenerative Medicinal Products Act (hereinafter “this Act”) is established in order to ensure the safety, quality, and efficacy of regenerative medicinal products and to protect patients’ interests. Anything that is not stipulated in this Act shall be governed by the Pharmaceutical Affairs Act and other applicable laws.

Related Regulations - Regenerative Medicinal Products Act

• Medical Devices Act - Article 71（第 71 條）
• Regenerative Medicinal Products Act - Article 21（第 21 條）
• Regenerative Medicinal Products Act - Article 2（第 2 條）
• Regenerative Medicinal Products Act - Article 3（第 3 條）
• Regenerative Medicinal Products Act - Article 4（第 4 條）
• Regenerative Medicinal Products Act - Article 5（第 5 條）
• Regenerative Medicinal Products Act - Article 6（第 6 條）